Brown Advisory
KRRO icon

Brown Advisory’s Korro Bio KRRO Stock Holding History

Brown Advisory’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-396
Closed -$7.32K – 1240
2023
Q3 		$7.32K Hold
396
– – ﹤0.01% 1186
2023
Q2 		$6.85K Hold
396
– – ﹤0.01% 1177
2023
Q1 		$9.96K Hold
396
– – ﹤0.01% 1201
2022
Q4 		$76.2K Hold
396
– – ﹤0.01% 1176
2022
Q3 		$35K Buy
+396
New +$40.2K ﹤0.01% 1118

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory's KRRO Position: Q4 2023 in Review

Brown Advisory sold out of Korro Bio (KRRO) in Q4 2023, closing a stake of 396 shares — an estimated $7.32K sold.

Brown Advisory first reported a position in KRRO in Q3 2022 and held it in 5 quarters. The position peaked at $76.2K in Q4 2022. 40 funds tracked by Wall St. Rank hold KRRO as of Q4 2023.

  • Brown Advisory reported no remaining Korro Bio position as of Q4 2023 after selling out during the quarter.
  • Brown Advisory sold 396 Korro Bio shares in Q4 2023, an estimated $7.32K.
  • Brown Advisory first reported a position in Korro Bio in Q3 2022 and held it in 5 quarters.
  • Brown Advisory's Korro Bio position peaked at $76.2K in Q4 2022.
  • 40 funds tracked by Wall St. Rank held Korro Bio as of Q4 2023.

Based on Brown Advisory's 13F filing for Q4 2023, filed 8 Feb 2024.